A2 Milk Products. Source: A2 Milk Company
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • The A2 Milk Company (A2M) and manufacturing partner Synlait Milk (SM1) receive Chinese regulatory approval to continue producing A2M infant formula until early next year
  • Synlait, which manufactures the A2M China-label infant formula, says it has received State Administration for Market Renewal (SAMR) for the product
  • This means Synlait will be able to continue manufacturing the product until February 21, 2023, before having to re-register the formula under new food safety standards
  • A2M says it will now work closely with Synlait to ensure the China-label infant formula meets the new food safety standards in China
  • Shares in A2 Milk are up 4.23 per cent to $5.80 at 10:31 am AEST, with Synlait trading grey at $3.12 at the same time.

The A2 Milk Company (A2M) and manufacturing partner Synlait Milk (SM1) have received Chinese regulatory approval to continue producing A2M infant formula until early next year.

Synlait, which manufactures the A2M China-label infant milk formula (IMF), said it had received State Administration for Market Renewal (SAMR) for the product.

The renewal will allow Synlait to produce A2 Milk’s current registered product in China until February 21, 2023, before having to re-register the formula under new food safety, or GB, standards.

A2M said it was now working “closely together” with Synlait to register its IMF products under the new regulations.

“We are pleased that our current product registration has been renewed, effectively to late February 2023, and we will continue to work collaboratively with Synlait and SAMR in relation to the registration of our China-label IMF product formulated in line with China’s new GB standards,” A2 Milk Managing Director and CEO David Bortolussi said.

“We remain focused on the China market and are looking forward to the opportunity to make our newly formulated infant milk product available to parents and infants in China.”

Meanwhile, the company noted that New Zealand’s Ministry for Primary Industries (MPI) had cooperation arrangements in place with Chinese regulators which positioned New Zealand well in relation to China’s registration processes.

A2 Milk owns roughly 20 per cent of Synlait.

Shares in A2 Milk were up 4.23 per cent to $5.80 at 10:31 am AEST, with Synlait trading grey at $3.12 at the same time.

A2M by the numbers
More From The Market Online
Nuclear explosion mushroom cloud concept

Week 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…
Image of eyes in closeup

Scientific conference spotlights PYC’s work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat…
Image of four gold necklaces

Sales growth pushes Lovisa’s fortunes (and shares) upwards

Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and…